Jason
Collins, BSc (Hons), MSc MTOPRA
Director,
Regulatory Science, Drugs & Biologics
< Back






Jason Collins is a Regulatory Consultant at RRG’s office in Camberley, Surrey, UK. He provides support to clients across a variety of regulatory activities, including clinical development, scientific advice (EMA, FDA and EU national) and Regulatory Agency negotiation right the way through to marketing authorisation and product life cycle management.

Jason has been responsible for preparation and submission of briefing documents (to support Scientific Advice Meetings), documentation for CTAs, including IBs and IMPDs, as well as preparation of documentation and management of EU MAA submissions (inc. national and DCP submissions) and US NDAs and INDs. Jason is the Quality Manager at RRG, being responsible for the Quality Management System, including reviewing, updating, maintaining and training staff on the quality procedures. He is also responsible for managing patient information leaflet user testing, and has conducted numerous user tests which have supported national, decentralised and centralised applications in the EU. Jason has an eye for electronic/technical documentation and has written templates and databases for the company and clients.

After graduating with an upper second class degree in Oceanography and Marine Biology at Southampton University, and continuing his education with an MSc in Management Science (also at Southampton University), Jason began his career at Stiefel Laboratories in 1999, working in the Regulatory group servicing the export markets (Ireland, Eastern Europe, Middle East and Africa). In 2004 he moved to Allergy Therapeutics as Regulatory Affairs Officer, later becoming Regulatory Affairs Manager, responsible for all regulatory affairs activities including new product development, life cycle management and regulatory operations across the company. Jason joined the RRG team as a consultant in 2011.

Since joining RRG, Jason has provided regulatory consultancy across a broad range of projects covering both medicinal products (including several biologicals) and medical devices, supporting numerous clients in relation to preparing documentation, managing projects (strategy, early phase development, INDs, MAAs), scientific advice meetings, and has conducted regulatory training for clients.